Drug Discovery

Survey fresh pharmacological responses to cardiovascular disease.

Science News

Heart Disease and Stroke Statistics - 2023 Update
Cancer Therapy–Related Hypertension
Polygenic Risk Scores for Cardiovascular Disease
Dr. Jeremiah Stamler, 'the father of preventive cardiology,' dies at 102
Impact of the COVID-19 Pandemic on Cardiovascular Science

Journals

Microvascular Dysfunction and Reduced Cardiac Stress Reactivity in Postural Orthostatic Tachycardia Associated With Postacute COVID-19
Transuterine Ultrasound-Guided Fetal Embolization of Vein of Galen Malformation, Eliminating Postnatal Pathophysiology

Trib1 Deficiency Promotes Hyperlipidemia, Inflammation, and Atherosclerosis in LDL (Low-Density Lipoprotein) Receptor Knockout Mice
β3AR-Dependent BDNF (Brain-Derived Neurotrophic Factor) Generation Limits Chronic Postischemic Heart Failure
A Nudge a Day Keeps the Influenza Away

Continuing Education

Audience members listen to a presentation during Scientific Sessions 2022 in Chicago, Illinois. Mark your calendar

Mark your calendars now to experience the premier global event focusing on improving health by championing scientific discovery and practice-changing educational content. We can't wait to see you November 2023!

The ATVB Council focuses on arteriosclerosis, thrombosis and vascular biology. The council advances research, addresses prevention, improves diagnosis and treatment, and works actively with other organizations. It shares reliable information through its annual conference, awards and lectures, and in the AHA’s journal, Arteriosclerosis, Thrombosis, and Vascular Biology.


The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.


The GPM Council seeks to advance discovery and translation of biological insights from genetics and omics technologies to improve cardiovascular and brain health through better risk prediction, treatment and prevention for patients. Our expertise spans genetics, genomics, genomic medicine, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, and population health.


American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses

Learn more about Professional Membership